Atlas Trials

Low Dose Ruxolitinib in Combination With Methylprednisolone

Clinical trial NCT04397367 · COMPLETED

Trial details

NCT number
NCT04397367
Sponsor
Chinese PLA General Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
aGVHDStem Cell Transplant Complications
Start date
2019-01-01
Primary completion
2020-07-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.